Mapi Research Trust Launches New Clinical Outcome Assessment (COA) Reference Portal

Lyon, France—May 3 2016 – Mapi Research Trust, the leading curator and license distributor of Clinical Outcome Assessments (COAs) has launched ePROVIDE™ a portal centralizing the industry’s most referenced Clinical Outcome Assessment (COA) resources and services including PROQOLID™, PROLABELS™, and PROINSIGHT™, the central resource for all published regulatory recommendations concerning use of COAs to determine treatment benefit and to inform drug approval as well as COA distribution and licensing.

The integrated PROVIDE™ platform (https://eprovide.mapi-trust.org/) allows users to personalize their COA information requests and have access to individualized responses from our dedicated information specialists that make up the PROVIDE™ team.

“The ePROVIDE solution is the scientific community’s foremost destination for Clinical Outcome Assessment and Patient-Reported Outcomes information” commented Katrin Conway, Mapi Research Trust’s Managing Director. “For nearly 3 decades the Mapi Research Trust has been the leading innovator in dissemination of COA information and the most trusted name in distribution of COA Instruments. Today the ePROVIDE solution provides a central location for all COA related information and aligns the efficiency of modern technology with a personalized service to access it both on an ad- hoc and subscription basis.

The Mapi Research Trust databases and researchers support nearly 50,000 annual searches from over 100 of the top Pharmaceutical company subscribers, top university researchers and thousands of COA licensing requests used in academic and clinical research; ePROVIDE expands access to the most often requested data used in health research, evaluation of patient therapeutic care including severity measures and treatment value assessment.

ePROVIDE enables users and subscribers:

  • Access to detailed information on over 1000 of the most common COAs used in clinical research out of Mapi Research Trust’s curated library of over 4000 instruments and their 40 000 translations.
  • Access to more than 1000 FDA and EMA labeling claims and details on the associated instruments
  • Single sign on access for all database contents: a powerful search engine allowing searches across the different databases
  • Collaborative space available for each subscriber, from which organizations’ researchers can share research information.

About Mapi Research Trust:

The Mapi Research Trust is the Non-Profit arm of Mapi Group and works in collaboration with Academic Researchers, Life-Science Companies and Regulatory bodies. It is the largest curator of Clinical Outcomes Assessments (COA) and their translations, the largest single COA licensing provider and the most trusted name in distribution of COA instruments exclusively representing over 270 questionnaires.

Mapi Group has over 40 years of experience supporting Life-Science companies in utilizing Patient Reported Outcomes (PRO) measures, Health Research Language Services, Value communications and Commercialization support, Strategic Regulatory Services, and gathering Real-World Evidence on Pharmaceuticals, Biologicals, and Medical devices. Mapi Group is the premier provider of Health Research and Commercialization services to Life-Science companies enabling Market Authorization, Market Access and Market Adoption of novel therapeutics. Visit http://www.mapigroup.com for more information.